Introduction: Brivaracetam was approved by the U.S. Food and Drug Administration (FDA) on February 19 for the adjuvant treatment of partial-onset seizures in patients 16 years of age and older. Compared with the previous generation drug levetiracetam, brivaracetam has a similar chemical structure and mechanism of action, and is the first antiepileptic drug approved by the FDA for the treatment of partial seizures since 2013.
Structural formula:
Properties
Summary
Buvacetam is a new generation of antiepileptic drug, which has been approved by FDA for the treatment of local seizures in epileptic patients aged 16 and over. It can be used in laboratory research and pharmaceutical research and development process.
CRO
